Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Osheroff

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Journal of Medicinal Chemistry|October 20, 2020
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over βJose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, et al.
Oncogene|November 25, 2003
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processingRyan J Whitmarsh, Charles Saginario, Ya Zhuo, et al.
ACS Infectious Diseases|December 23, 2025
Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen <i>Bacillus anthracis</i> and Its Type II TopoisomerasesChelsea A Mann, Stephanie A Halasohoris, Annette M Gray, et al.
Journal of Medicinal Chemistry|May 2, 2022
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis ActivityPreshendren Govender, Rudolf Müller, Kawaljit Singh, et al.
Blood|November 4, 2009
Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemiaAshley N Mays, Neil Osheroff, Yuanyuan Xiao, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial SpectrumYanran Lu, Chelsea A Mann, Sheri Nolan, et al.
The New England Journal of Medicine|April 15, 2005
DNA topoisomerase II in therapy-related acute promyelocytic leukemiaAnita R Mistry, Carolyn A Felix, Ryan J Whitmarsh, et al.
Medical Science Educator|January 2, 2018
Teaching Biochemistry and Genetics to Students of Dentistry, Medicine, and Pharmacy 6<sup>th</sup> International Conference of the Association of Biochemistry Educators (ABE) Clearwater Beach, FL, USA, May 7-11, 2017Eric C Niederhoffer, Susan D Cline, Neil Osheroff, et al.
Blood|July 25, 2008
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosisSyed Khizer Hasan, Ashley N Mays, Tiziana Ottone, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Journal of Medicinal Chemistry|October 20, 2020
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over βJose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, et al.
Oncogene|November 25, 2003
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processingRyan J Whitmarsh, Charles Saginario, Ya Zhuo, et al.
ACS Infectious Diseases|December 23, 2025
Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen <i>Bacillus anthracis</i> and Its Type II TopoisomerasesChelsea A Mann, Stephanie A Halasohoris, Annette M Gray, et al.
Journal of Medicinal Chemistry|May 2, 2022
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis ActivityPreshendren Govender, Rudolf Müller, Kawaljit Singh, et al.
Blood|November 4, 2009
Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemiaAshley N Mays, Neil Osheroff, Yuanyuan Xiao, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial SpectrumYanran Lu, Chelsea A Mann, Sheri Nolan, et al.
The New England Journal of Medicine|April 15, 2005
DNA topoisomerase II in therapy-related acute promyelocytic leukemiaAnita R Mistry, Carolyn A Felix, Ryan J Whitmarsh, et al.
Medical Science Educator|January 2, 2018
Teaching Biochemistry and Genetics to Students of Dentistry, Medicine, and Pharmacy 6<sup>th</sup> International Conference of the Association of Biochemistry Educators (ABE) Clearwater Beach, FL, USA, May 7-11, 2017Eric C Niederhoffer, Susan D Cline, Neil Osheroff, et al.
Blood|July 25, 2008
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosisSyed Khizer Hasan, Ashley N Mays, Tiziana Ottone, et al.
Pageof 15